Status:
COMPLETED
Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Hepatitis A
Measles
Eligibility:
All Genders
12-17 years
Phase:
PHASE4
Brief Summary
Two doses each of Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella \[Oka/Merck\] Virus Vaccine Live will be given concomitantly or non-concomitantly. Safety data will be coll...
Eligibility Criteria
Inclusion
- Negative clinical history of hepatitis A, measles, mumps, rubella, varicella (chickenpox), and/or zoster
- No other vaccinations scheduled to be administered at the time of the first or second doses of VAQTA(TM) and ProQuad(TM)
Exclusion
- Previously vaccinated with any hepatitis A vaccine, measles, mumps, rubella, and/or varicella vaccine either alone or in any combination
- History of allergy to any vaccine component
- History of seizure disorder
- Immunosuppressed including congenial and acquired conditions and immunosuppressive therapy
- Known severe thrombocytopenia or any other coagulation disorder that would contraindicate intramuscular injections
- Recent (\<72 hours) febrile illness (\>100.3 degrees F \[\>37.9 degrees C\] oral equivalent) prior to study vaccination.
Key Trial Info
Start Date :
March 26 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 15 2008
Estimated Enrollment :
1800 Patients enrolled
Trial Details
Trial ID
NCT00326183
Start Date
March 26 2007
End Date
January 15 2008
Last Update
February 4 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.